Iba

LOUVAIN-LA-NEUVE, Belgium, September 2, 2010 - IBA (Ion Beam Applications S.A.), developer of equipment and pharmaceuticals dedicated to cancer diagnosis and treatment, announced today that it has sold the prototype of its next generation carbon therapy system to the French company CYCLHAD (un CYCLotron pour l'HADronthrapie, or a Cyclotron for Hadron Therapy).